KR20000065345A - Composition of therapeutical agents for a burn - Google Patents

Composition of therapeutical agents for a burn Download PDF

Info

Publication number
KR20000065345A
KR20000065345A KR1019990011537A KR19990011537A KR20000065345A KR 20000065345 A KR20000065345 A KR 20000065345A KR 1019990011537 A KR1019990011537 A KR 1019990011537A KR 19990011537 A KR19990011537 A KR 19990011537A KR 20000065345 A KR20000065345 A KR 20000065345A
Authority
KR
South Korea
Prior art keywords
ointment
composition
burn
weight
treatment
Prior art date
Application number
KR1019990011537A
Other languages
Korean (ko)
Other versions
KR100318812B1 (en
Inventor
김재열
Original Assignee
김재열
안기주
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김재열, 안기주 filed Critical 김재열
Priority to KR1019990011537A priority Critical patent/KR100318812B1/en
Publication of KR20000065345A publication Critical patent/KR20000065345A/en
Application granted granted Critical
Publication of KR100318812B1 publication Critical patent/KR100318812B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/241Lead; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: A composition containing herb medicine for treatment of burn is provided, which eliminates feeling of burn by fires and pain, and shows good skin-reproduction effect when applied on burn site as a preparation for external. CONSTITUTION: A process for the preparation of composition for treatment of burn comprises of: drying and pulverizing the Haooysitum Rubrum 40-44wt.%, the marble powder 20-23wt.%, the Yellow stone(Whang-Dan) 20-23wt.%. and the Rhei Rhizoma 10-14wt.% to fine powder, and mixing; adding pharmaceutically acceptable ointment base(e.g., Simple ointment, White ointment, Salicylated phenol ointment; Ichthammol ointment, Zinc oxide ointment) in the weight ratio of 5:5. The composition for treatment of burn is applied for 3-4-times per day on a burn site. A process for the preparation of Simple ointment comprises of: melting Yellow beeswax, vegetable oil on water bath completely; and mixing the compound till which be hard.

Description

화상치료용 조성물{Composition of therapeutical agents for a burn}Composition of therapeutical agents for a burn

본 발명은 화상치료용 조성물에 관한 것으로, 구체적으로는 적석지, 한수석, 황단 및 대황 등의 분말을 혼합하여 사용한 화상치료용 조성물에 관한 것이다.The present invention relates to a composition for treating burns, and more particularly, to a composition for treating burns using a mixture of powders such as red stone paper, hanseok, yellow tablets and rhubarb.

일반적으로 한의서에 기재된 한방피부용 약재로는 광물성으로서 유황, 비석, 우황, 경분, 연단, 노감석, 붕사 등 7종이 있고 동물성 약재로는 반묘, 노봉방 등 2종이 있으며, 식물성으로는 대풍자, 목극피 등 2종류가 있어서, 그것들을 적절히 선택하여 소정의 비율로 배합함으로서 한방외과 피부질환 치료용으로 사용하여 왔었다. 한방의 원전인 본초강목, 동의보감 (1596년 한국발간)과 근래 발간된 한방외과처방을 집대성한 '한방외과'를 참조하면 외과용 외부질환 처방예가 1000여종 정도 있고 그 중 고약처방이 약 80여 종 있는데, 이들 처방에서는 원약재로서 상기한 광물, 동물, 식물 등 11종의 약재를 여러 가지 종류와 비율로 처방한 것으로 되어 있다. 그러나 상기한 기존의 한방약재로는 치료효과가 없거나 치료시간이 장기간 소요되거나 부분적인 치료효과만 있어서 실효성이 적을 뿐만 아니라 많은 종류의 약재를 혼합하여야 하기 때문에 고가의 제조원가가 소요되는 결점이 있었다.In general, there are 7 kinds of herbs for herbal skin described in the oriental medicine as minerals such as sulfur, zeolite, cow sulfur, hard powder, podium, sensitized stone and borax. There have been two types, and they have been used for the treatment of oriental surgical skin diseases by appropriately selecting them and blending them in a predetermined ratio. If you refer to `` Oriental Surgery '', which is a collection of herbal medicine, Dongbobom (published in Korea in 1596) and recently published medicinal herbal medicine, about 1000 kinds of surgical external diseases are prescribed, and about 80 kinds of plaster prescription However, in these prescriptions, 11 kinds of medicines such as minerals, animals and plants mentioned above are prescribed in various kinds and ratios as raw medicines. However, the above-mentioned traditional herbal medicines have a drawback in that they do not have a therapeutic effect or require a long time for treatment or have a partial treatment effect, and thus have low effectiveness and require expensive manufacturing costs.

본 발명에 사용한 조성물 각각의 알려진 특징으로는 다음과 같은 것들이 있다.Known features of each of the compositions used in the present invention include the following.

대황 (大黃, Rhei Rhizoma)은 중국 서부가 원산지인 마디풀과에 속하는 여러해살이풀인데, 주로 장군풀의 뿌리를 일컫는 말이며, 당대황(唐大黃), 금문대황(錦紋大黃) 또는 장군(將軍) 등의 이름으로 불리기도 한다. 그 주성분은 안트라센 글루코시드로 알려져 있다. 대황은 예로부터 잘 알려진 약용식물이며 원뿌리 또는 원뿌리의 껍질을 말려서 완하제, 건위제로서 상습변비와 소화불량증에 복용해 왔다. 또한 대황은 그 성질이 차고 맛이 달며 통리(通利)하는 힘이 많아, 대소변 불통, 조열(潮熱), 헛소리, 잠꼬대, 적취(積聚), 어혈 같은 병에 사용된다. 또한 소염성을 지닌 하제(下劑)라는 것이 특징이다. 한방에서는 사하약, 고혈압 치료제, 해열 소염 진통제, 피부질환 치료제로 보이는 처방 (삼황사심탕, 인진호탕, 소승기탕, 조위승기탕, 대황목단피탕 등)에 배합되어 왔다. 더 많은 응용으로는 위장관 출혈 치료제, 조경제, 건위제, 완하약으로 사용하기도 한다. 한편 대황과 같은 마디풀과 식물에 주로 함유되어 있는 화합물인 에모딘은 항암효과가 있는 것으로 알려져 있다. 그러나 아직까지 대황이 화상치료용 조성물에 사용된 예는 보고된 바 없다.Rhubarb (大黃, Rhei Rhizoma) is a perennial herb that belongs to the Madipulaceae family, which is native to western China. It may also be called (將軍). Its main ingredient is known as anthracene glucoside. Rhubarb is a well-known medicinal plant since ancient times, and it has been taken for constant constipation and dyspepsia as a laxative and dry stomach agent by drying the root of the root or root. In addition, rhubarb is cold in nature, has a sweet taste, and has a lot of power, and is used for diseases such as fecal discomfort, heat, bullshit, drool, red wine, and blood. It is also characterized by anti-inflammatory laxatives. Herbal medicine, high blood pressure treatment, antipyretic anti-inflammatory analgesic, skin disease treatment (Samhwangsasimtang, Injinho-tang, Soseunggi-tang, Jowiseunggi-tang, Daehwangmokdanpitang, etc.) has been combined. More applications are also used for the treatment of gastrointestinal bleeding, crude economy, stomach and laxatives. Meanwhile, emodine, a compound mainly contained in plants and plants such as rhubarb, is known to have an anticancer effect. However, there have not been reported examples of rhubarb used in the composition for treating burns.

적석지(赤石脂)는 도화석(桃花石)이라고도 하는데, 이는 산화철을 함유하는 도토(陶土)로 규산 알루미늄, 탄산칼슘, 황산 마그네슘 등의 성분으로 구성되어 있다. 또한 적석지는 수렴(收斂), 지혈 및 설사를 그치게 하는 효과가 있지만 위에 지장을 줄 우려가 있으므로, 위에 장해가 있는 사람, 위가 약한 사람에 대해서는 주의가 필요하다.Red stone is also known as dohwaseok (桃花 石), which is a clay containing iron oxide is composed of components such as aluminum silicate, calcium carbonate, magnesium sulfate. In addition, rediscovered paper has the effect of stopping convergence, hemostasis, and diarrhea, but it may interfere with the stomach, so care should be taken for those with a stomach disorder and those with a weak stomach.

한수석(寒水石)은 응수석(凝水石)이라고도 하며, 소금의 간수가 굳어서 돌처럼 된 것을 말한다. 열을 내리고 뱃속의 덩어리를 삭게 하며, 사기(邪氣)를 제거하는 목적으로 쓰인다. 풍인탕(風引湯)이라고 하는 처방에 배합된다.Hansuseok (寒水石) is also known as jungsuseok (凝 水 石), it means that the salt water is hardened into a stone. It is used for the purpose of lowering heat, cutting off lumps in the stomach, and removing fraud. It is formulated in a prescription called Pungin-tang.

황단(黃丹)은 적취와 열병에 효과가 있으며, 통증을 가라앉히는 작용을 한다. 또한 새살을 돋게 만들고 담을 치료하는 효과가 있다.Yellow dandelion (黃丹) is effective in capturing and fever, and works to relieve pain. It also has the effect of stimulating birds and healing the phlegm.

화상은 일반적으로 열, 화학약품, 전기 또는 방사선에 접촉하여 생기는 신체 피부의 손상을 말한다. 의학적으로는 열상(熱傷)이라고 하는데, 가열물이나 끓는 물의 증기에 의한 화상은 증기열상이라고도 한다.Burns generally refer to damage to the body's skin caused by contact with heat, chemicals, electricity, or radiation. Medically, it is called thermal burn, and burns caused by steam of heated water or boiling water are also called steam burns.

화상은 그 면적과 피부손상의 깊이에 따라 3가지로 구분된다. 제 1 도 (紅班性) 화상은 빨갛게 되고 부풀어서 아프며, 나은 뒤 변색된다. 제 2 도 (水疱性) 화상은 물집이 생기고 진무르며, 나은 뒤에 변색된다. 제 3 도 (壞死性) 화상은 조직에 괴사와 궤양이 생기며, 나은 뒤에 흉터, 옥죄임, 켈로이드 등이 생기는 일이 많다. 화상의 범위가 넓어지면 발열 및 호흡 곤란과 더불어 체내의 수분이나 단백질을 상실하여 탈수상태, 쇼크 및 신부전(腎不全)을 일으키고 상처의 감염이 수반된다. 성인의 경우, 보통 신체 전체 면적의 3분의 1 이상 화상을 입게 되면 생명이 위험하게 된다. 심한 화상의 치료시 제일 먼저 해야 할 것은 수혈로서 이것에 의해 체액과 염류의 불균형을 바로잡은 후 감염 방지, 상처의 치료, 피부이식 등을 한다.Burns are classified into three types according to their area and depth of skin damage. First-degree burns become red, swollen and painful, and later discolor. Second-degree burns are blistered and sore, and later discolored. Third-degree burns cause necrosis and ulceration in tissues, and are often followed by scars, jails, and keloids. A wider range of burns leads to fever and difficulty breathing, loss of water and protein in the body, leading to dehydration, shock and kidney failure, and infection of the wound. In adults, burns of more than one-third of the body's total area are life-threatening. The first thing to do in the treatment of severe burns is blood transfusion, which corrects the imbalance of body fluids and salts, and then prevents infection, treats wounds, and transplants skin.

이에 본 발명자들은 대황, 적석지, 한수석 및 황단으로 구성되는 조성물이 화상치료에 매우 뛰어난 효과가 있음을 알아내어 본 발명을 완성하였다.The present inventors have completed the present invention by finding that the composition consisting of rhubarb, red stone paper, hansuseok and yellow macula has an excellent effect on burn treatment.

본 발명의 목적은 화상치료용 조성물을 제공하는 것이다.It is an object of the present invention to provide a composition for treating burns.

상기 목적을 달성하기 위하여 본 발명에서는 적석지, 한수석, 황단 및 대황로 구성되는 화상치료용 조성물 및 이들과 연고기제를 혼합하여 외용제재를 제조하는 방법을 제공한다.In order to achieve the above object, the present invention provides a composition for the treatment of burns consisting of red stone, hansuseok, macula and rhubarb, and a method for preparing an external preparation by mixing them with a mutant.

이하 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

구체적으로 본 발명은 적석지 40-44 중량%, 한수석 20-23 중량%, 황단 20-23 중량% 및 대황 10-14 중량%로 이루어진 화상치료용 조성물을 제공한다.Specifically, the present invention provides a composition for treating burns consisting of 40-44% by weight of red paper, 20-23% by weight of sulphide, 20-23% by weight of dandan and 10-14% by weight of rhubarb.

또한 본 발명은 상기 조성물에 더하여 약제학적으로 허용되는 연고기제를 배합하여 이루어진 화상치료용 조성물을 제공한다. 이 때, 연고기제로는 유지성기제로서 바셀린, 파라핀, 식물유, 돈지, 왁스류 및 단미연고 중에서 선택되는 것을 사용할 수 있다. 본 연고화의 과정은 사용상의 편리를 위한 것으로서, 상기 조성물의 세말 배합된 분말형태만으로도 탁월한 치료효과를 보인다.In another aspect, the present invention provides a composition for the treatment of burns made by combining a pharmaceutically acceptable ointment in addition to the composition. In this case, as the oleaginous agent, those selected from petroleum jelly, paraffin, vegetable oil, lard, wax, and sweet rice ointment may be used. The process of the ointment is for convenience of use, it shows an excellent therapeutic effect only in the form of powder formulated in the composition.

또한 본 발명은 적석지, 한수석, 황단 및 대황을 건조하고 미세하게 분쇄하여 상기 조성대로 배합한 후, 이를 약제학적으로 허용되는 연고기제와 1:9 - 9:1의 비율로 혼합하는 것을 특징으로 하는 화상치료용 조성물의 제조방법을 제공한다.In another aspect, the present invention is characterized in that the reddish paper, Hansuseok, yellow algae and rhubarb are dried and finely pulverized and blended according to the above composition, and then mixed with a pharmaceutically acceptable meat preparation in a ratio of 1: 9-9: 1. It provides a method for producing a composition for burn treatment.

또한 본 발명은 적석지 40-44 중량%, 한수석 20-23 중량%, 황단 20-23 중량% 및 대황 10-14 중량%로 이루어진 창상 또는 화농상 치료용 조성물을 제공한다.In another aspect, the present invention provides a composition for the treatment of wound or suppuration consisting of 40-44% by weight of red paper, 20-23% by weight of sulphide, 20-23% by weight of yellow sand and 10-14% by weight of rhubarb.

상기 조성으로 이루어진 화상치료용 조성물은 화상 부위에 1일 3-4회 도포한다. 유효량은 화상의 정도나 그 환부의 면적에 따라서 달라질 수 있으므로 구체적으로 한정할 수는 없다.The composition for burn treatment consisting of the composition is applied to the burn site 3-4 times a day. The effective amount may vary depending on the extent of the burn or the area of the affected part, and therefore cannot be specifically limited.

본 발명의 상기 조성물로 제조된 외용제재를 화상부위에 도포한 결과 도포 후 극심한 화기열감이 소멸되고 통증이 완화되면서 환자가 곧 안정되고 단시일에 조직세포가 소생하여, 그 화상치유효과가 매우 뛰어남을 알 수 있었다.As a result of applying the external preparation prepared in the composition of the present invention to the burned area, after the application of the extreme heat sensation disappears and pain is alleviated, the patient is soon stabilized and tissue cells are revived in a short time, and the burn healing effect is very excellent. Could know.

또한, 본 발명의 상기 조성물로 제조된 외용제재는 창상 또는 화농상에 대하여서도 뛰어난 치료효과를 나타낸다.In addition, the external preparation prepared from the composition of the present invention exhibits excellent therapeutic effects even on wounds or purulent wounds.

이하 본 발명을 실시예에 의하여 더욱 상세하게 설명한다.Hereinafter, the present invention will be described in more detail with reference to Examples.

단, 하기 실시예들은 본 발명을 예시하는 것으로 본 발명의 내용이 실시예에 의해 한정되는 것은 아니다.However, the following examples are illustrative of the present invention, and the content of the present invention is not limited by the examples.

한편, 실시예에 앞서 본 발명의 조성물을 제조하기 위한 연고기제를 하기 제조예의 조성으로 제조하였다. 이는 약전에 기재된 처방예를 따른 것이다.On the other hand, prior to the embodiment was prepared in the composition of the following preparation of the ointment for producing a composition of the present invention. This follows the prescription example described in the pharmacopeias.

〈제조예 1〉 단미연고의 제조<Manufacture example 1> Production of sweet rice ointment

다음과 같은 배합으로 단미연고 (Simple ointment(KP VI))를 제조하였다.Simple ointment (KP VI) was prepared by the following formulation.

황납 (Yellow beeswax) 330Yellow beeswax 330

식물유 (Vegetable Oil) q.s.Vegetable Oil q.s.

전체량 1000Total quantity 1000

이상을 수욕상에서 가온하여 녹이고 완전히 녹으면 가온을 중지하고 굳을 때까지 혼화하여 만든다.When the ideal is melted by warming in the water bath and completely dissolved, stop the heating and mix until it hardens.

〈제조예 2〉 백색연고의 제조Production Example 2 Preparation of White Ointment

다음과 같은 배합으로 백색연고 (White ointment (KP VI))를 제조하였다.White ointment (KP VI) was prepared by the following formulation.

백납 (White beeswax) 50White beeswax 50

세스퀴올레인산소르비탄 (Sorbitan sesquioleate) 20Sorbitan sesquioleate 20

백색바셀린 (White petrolatum) q.s.White petrolatum q.s.

전체량 1000Total quantity 1000

백납을 수욕상에서 가온하여 녹이고 이것에 세스퀴올레인산소르비탄과 백색바셀린을 가하여 녹인 다음 가온을 중지하고 굳을 때까지 교반하면서 만든다.The wax is heated in a water bath to dissolve it, and it is dissolved by adding sesquioleate sorbitan and white petrolatum, and then the heating is stopped and stirred until it hardens.

〈제조예 3〉 살리실산-페놀 연고의 제조<Production example 3> Production of salicylic acid phenol ointment

다음과 같은 배합으로 살리실산-페놀 연고 (Salicylated phenol ointment (KP VI))를 제조하였다.Salicylic acid-phenol ointment (KP VI) was prepared by the following formulation.

페놀 (phenol) 30Phenol 30

살리실산 (Salicylic acid) 50Salicylic acid 50

방향제 (Aromatics) q.s.Aromatics q.s.

백색바셀린 (White petrolatum or Ointment base) q.s.White petrolatum or Ointment base q.s.

전체량 1000Total quantity 1000

살리실산을 소량의 에테르 또는 에탄올을 가하여 습윤시켜 충분히 연화하여 미세말로 한 다음 백색바셀린 소량에 연화한다. 따로 미리 수욕상에서 용해시킨 페놀 및 방향제를 함께 연화시킨 후, 잔여량의 백색바셀린을 가하여 연화하여 전질 균등하게 만들다.Salicylic acid is moistened with a small amount of ether or ethanol, softened sufficiently to fine powder, and then softened to a small amount of white petrolatum. Separately, the phenol and fragrances previously dissolved in the water bath are softened together, followed by addition of the remaining amount of white petrolatum to soften the whole.

〈제조예 4〉 이크타몰 연고의 제조<Production example 4> Production of iktamol ointment

다음과 같은 배합으로 이크다몰 연고 (Ichthammol ointment (KP VI))를 조제하였다.Ichhammol ointment (KP VI) was prepared by the following formulation.

이크타몰 (Ichthammol) 100Ichthammol 100

정제 라놀린 (Purified lanolin) 100Purified lanolin 100

바셀린 (Vaselin) 800Vaselin 800

전체량 1000Total quantity 1000

이크타몰과 정제 라놀린을 먼저 연고판상에서 연화한 후 바셀린을 가하여 전질 균등한 제품을 만든다.Iktamol and purified lanolin are first softened on an ointment and then petroleum jelly is added to make a homogeneous product.

〈제조예 5〉 아연화 연고의 제조<Manufacture example 5> Production of galvanized ointment

다음과 같은 배합으로 아연화 연고 (Zinc oxide ointment (KP VI))를 제조하였다.Zinc oxide ointment (KP VI) was prepared by the following formulation.

산화아연 (Zinc oxide) 200Zinc Oxide 200

정제라놀린 (Purified lanolin) 70Purified lanolin 70

백색연고 (White ointment) q.s.White ointment q.s.

전체량 1000Total quantity 1000

산화아연을 200호 (75 ㎛) 체에 통과시킨 다음 정제라놀린과 먼저 연화하고 백색연고를 가해서 다시 연화하여 전질 균등하게 만든다. 백색연고 대신에 백납 백색바세린을 넣을 수도 있다.Zinc oxide is passed through a No. 200 (75 μm) sieve and then softened with purified lanolin first, followed by the addition of white ointment to soften it evenly. Instead of white ointment, white lead white petrolatum may be added.

〈실시예 1-6〉 화상치료용 조성물의 제조<Example 1-6> Preparation of the composition for burn treatment

하기 표 1 과 같은 배합으로 화상치료용 조성물을 제조하였다.To prepare a composition for burn treatment in the formulation as shown in Table 1.

화상치료용 제재의 조성Composition of Burn Treatment 적석지Red earth 한수석Han Su-seok 황단Yellow 대황rhubarb 연고기제Meat 실시예 1Example 1 4343 2222 2222 1313 사용 안 함not used 실시예 2Example 2 4343 2222 2222 1313 조제예 1을 100Formulation 1 to 100 실시예 3Example 3 4343 2222 2222 1313 조제예 2을 100Formulation 2 to 100 실시예 4Example 4 4343 2222 2222 1313 조제예 3을 100Formulation 3 100 실시예 5Example 5 4343 2222 2222 1313 조제예 4을 100Formulation 4 100 실시예 6Example 6 4343 2222 2222 1313 조제예 5을 100Formulation 5 100 단위는 gUnit is g

적석지, 한수석, 황단 및 대황을 건조시키고 미세하게 분쇄하여 상기 표 1 의 조성대로 배합하였다. 이중 일부는 그대로 두고 나머지는 약제학적으로 허용되는 연고기제, 즉 조제예 1 - 5 에서 얻은 것과 5:5의 비율로 혼합하였다.The reddish paper, the hanseok, the yellow end and the rhubarb were dried and finely pulverized and blended according to the composition of Table 1 above. Some of them were left intact and the others were mixed in a ratio of 5: 5 to those obtained in pharmaceutically acceptable meat preparations, namely Formulations 1-5.

〈실험예 1〉 독성 및 부작용 여부 조사Experimental Example 1 Investigation of Toxicity and Side Effects

상기 실시예 1 - 6 에서 얻은 제재를, 하루 2회씩 15일 동안 사람 팔 1.5×1.5 ㎠ 넓이의 피부에 적용하여 독성 및 부작용 여부를 알아보았다.The preparations obtained in Examples 1-6 were applied to the skin of human arm 1.5 × 1.5 cm 2 area twice a day for 15 days to determine the toxicity and side effects.

15일 후에 상기 실시예 1 - 6 에서 얻은 제재를 적용한 사람 팔의 피부에서 외형상 특별한 이상은 나타나지 않았다. 따라서 상기 실시예 1 - 6 에서 얻은 제재는, 사람의 피부에 대하여 독성 및 부작용을 일으키지 않음을 알 수 있었다.After 15 days, no abnormalities in appearance were observed in the skin of the human arm to which the preparations obtained in Examples 1 to 6 were applied. Therefore, it was found that the preparations obtained in Examples 1 to 6 did not cause toxicity and side effects to human skin.

〈실험예 2〉 화상치료 효과 조사Experimental Example 2 Burn Treatment Effect

상기 실시예 1 - 6 에서 얻은 제재를 사용하여 그 화상치료 효과를 조사하기 위하여 임상실험을 실시하였다. 1도 화상의 대상자 23명, 2도 화상의 대상자 14명, 3도 화상의 대상자 3명에 대하여, 본 발명의 제재의 화상치료 효과를 조사하였다. 임상실험 결과는 다음의 표 2 에 나와 있다. 상기 실시예 1 - 6 의 제재에 대한 임상실험 결과에서, 화상치료 효과는 연고기제의 사용여부 또는 그 연고기제의 종류와 상관없었으며, 표 2 의 결과는 상기 실시예 1 - 6 의 제재에 대한 평균을 나타낸다.Clinical trials were conducted to investigate the effects of burn treatment using the agents obtained in Examples 1-6. 23 subjects of first degree burns, 14 subjects of second degree burns and three subjects of third degree burns were examined for the effect of burn treatment of the agent of the present invention. The clinical trial results are shown in Table 2 below. In the clinical trial results of the formulations of Examples 1-6, the effect of burn treatment was not related to the use of the medicinal agent or the type of the medicinal agent, and the results of Table 2 were based on the formulations of Examples 1-6. The average is shown.

임상실험 결과Clinical Trial Results 5-6 일5-6 days 7-8 일7-8 days 17-20 일17-20 days 21-23 일21-23 days 50-55 일50-55 days 전체인원total members 1도 화상1st degree burns 17 명17 people 6 명6 people -- -- -- 23 명23 people 2도 화상Second degree burns -- -- 9 명9 people 5 명5 people -- 14 명14 people 3도 화상A third degree burn -- -- -- -- 3 명3 people 3 명3 people

상기 임상실험 결과에서 볼 수 있듯이, 본 발명의 조성물로 이루어진 제재는 화상치료에 탁월한 효과를 나타낸다.As can be seen from the clinical trial results, the agent made of the composition of the present invention shows an excellent effect on burn treatment.

본 발명의 화상치료용 조성물로 제조된 제재는, 환부에 도포하면 화기열감과 통증이 사라지고 단시일내의 화상치유효과 및 피부재생효과가 탁월하다.The preparation made of the composition for treating burns of the present invention, when applied to the affected area, heat and pain disappears, and the burn healing effect and skin regeneration effect within a short period of time are excellent.

Claims (5)

적석지 40-44 중량%, 한수석 20-23 중량%, 황단 20-23 중량% 및 대황 10-14 중량%로 이루어진 화상치료용 조성물.Burn treatment composition consisting of 40-44% by weight of red paper, 20-23% by weight, 20-23% by weight of yellow algae and 10-14% by weight of rhubarb. 제 1 항에 있어서, 상기 조성물에 더하여 약제학적으로 허용되는 연고기제를 배합하여 이루어진 화상치료용 조성물.The composition for treating burns according to claim 1, wherein a pharmaceutically acceptable ointment is added to the composition. 제 2 항에 있어서, 연고기제는 유지성기제로서 바셀린, 파라핀, 식물유, 돈지, 왁스류 및 단미연고 중에서 선택되는 것을 특징으로 하는 화상치료용 조성물.The composition for treating burns according to claim 2, wherein the ointment is selected from petrolatum, paraffin, vegetable oil, lard, wax and sweet ointment as an oil-based base. 적석지, 한수석, 황단 및 대황을 건조하고 미세하게 분쇄하여 제 1 항의 조성대로 배합한 후, 이를 약제학적으로 허용되는 연고기제와 1:9 - 9:1의 비율로 혼합하는 것을 특징으로 하는 화상치료용 조성물의 제조방법.Dry, finely crushed red stone paper, corn kernels, yellow algae and rhubarb and mix them according to the composition of claim 1, and then mix them with the pharmaceutically acceptable meat preparation in a ratio of 1: 9-9: 1. Method for the preparation of a therapeutic composition. 적석지 40-44 중량%, 한수석 20-23 중량%, 황단 20-23 중량% 및 대황 10-14 중량%로 이루어진 창상 또는 화농상 치료용 조성물.A composition for treating wounds or purulent conditions consisting of 40-44% by weight of red paper, 20-23% by weight, 20-23% by weight, and 10-14% by weight of rhubarb.
KR1019990011537A 1999-04-02 1999-04-02 Composition of therapeutical agents for a burn KR100318812B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019990011537A KR100318812B1 (en) 1999-04-02 1999-04-02 Composition of therapeutical agents for a burn

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019990011537A KR100318812B1 (en) 1999-04-02 1999-04-02 Composition of therapeutical agents for a burn

Publications (2)

Publication Number Publication Date
KR20000065345A true KR20000065345A (en) 2000-11-15
KR100318812B1 KR100318812B1 (en) 2001-12-28

Family

ID=19578597

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019990011537A KR100318812B1 (en) 1999-04-02 1999-04-02 Composition of therapeutical agents for a burn

Country Status (1)

Country Link
KR (1) KR100318812B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2678994C1 (en) * 2018-03-29 2019-02-05 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Ointment for treatment of radiation-thermal burns and method for treatment thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1072856A (en) * 1992-10-13 1993-06-09 杨象新 The method for making of the spray burn-curing liquid of treatment burn
KR950013497A (en) * 1993-11-05 1995-06-15 이공희 How to prepare powder for skin pack
CN1104909A (en) * 1994-01-03 1995-07-12 范世英 Medicine for scald
CN1109771A (en) * 1994-08-23 1995-10-11 马修身 Ointment for curing burn and scald and producing process thereof
KR0180994B1 (en) * 1996-05-14 1999-03-20 최진영 Soap composition
CN1269229A (en) * 1999-04-07 2000-10-11 张晓涛 Dressed medicine powder for burns, scalds and frostbite and its preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2678994C1 (en) * 2018-03-29 2019-02-05 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Ointment for treatment of radiation-thermal burns and method for treatment thereof

Also Published As

Publication number Publication date
KR100318812B1 (en) 2001-12-28

Similar Documents

Publication Publication Date Title
Guarino et al. Ethnobotanical study of the Sannio area, Campania, southern Italy
JP2019517533A (en) External pharmaceutical composition for treatment of various wound wounds of skin and preparation method thereof
CN106433092A (en) Herbal modified material based on PU foam as well as preparation method and application of herb modified material
CN101310748A (en) Ointment for treating empyrosis
CN101708316B (en) Ointment for treating chilblain
CN103070951B (en) Externally used medicinal composition for treating cattle mange and preparation method thereof
KR100318812B1 (en) Composition of therapeutical agents for a burn
CN114903968A (en) Herbal composition, preparation method and application
CN100502905C (en) Chinese medicinal preparation for anti bacteria and promoting tissue regeneration
CN102836306B (en) Traditional Chinese medicine combination for treating horse traumatic injuries and preparation method of same
CN103142727B (en) Chinese herbal medicine composition for treating burning and scalding of human body
CN105168091A (en) Telangiectasis removing mask powder and preparation method thereof
CN104623040A (en) Nursing composition with wound sterilization and inflammation diminishment effects and preparation method thereof
CN104398649A (en) Medicinal oil for treating burn and scald and preparation method thereof
CN105232849A (en) Plaster for treating burns
Dweck Ethnobotanical use of plants. Part 4: The American continent
CN100355437C (en) Medicine for treating scald and burn and preparing method
CN110151916A (en) A kind of ointment and preparation method thereof for treating onychomycosis
CN109908312B (en) Hemorrhoid ointment and preparation method thereof
CN108379374A (en) It is a kind of to be used to treat ointment of pernio and preparation method thereof
WO2022097105A1 (en) Burn ointment using herbal compounds to repair a variety of infectious wounds
KR102127246B1 (en) The compositions for skin care containing Palmatum Rhei Rhizoma components and thereof manufacturing method
KR0167535B1 (en) An adhesive plaster for burn therapeutic agent
CN106334176A (en) Chilblain cream capable of relieving swelling, pain and itching and preparation method thereof
CN105125926A (en) Medical powder for treating burns and scalds and preparation method of medical powder

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20050613

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee